<i>In silico</i> studies on recreational drugs: 3D quantitative structure activity relationship prediction of classified and <i>de novo</i> designer benzodiazepines-Reference-Cited by-同舟云学术

In silico studies on recreational drugs: 3D quantitative structure activity relationship prediction of classified and de novo designer benzodiazepines

Published:2022-09-05 Issue:1 Volume:101 Page:40-51
ISSN:1747-0277
Container-title:Chemical Biology & Drug Design
language:en
Short-container-title:Chem Biol Drug Des

Author:

Catalani Valeria¹,Floresta Giuseppe²,Botha Michelle¹,Corkery John Martin¹,Guirguis Amira¹³,Vento Alessandro⁴,Abbate Vincenzo²,Schifano Fabrizio¹

Affiliation:

1. Psychopharmacology, Drug Misuse and Novel Psychoactive Substances Research Unit, School of Life and Medical Sciences University of Hertfordshire Hatfield UK

2. Department of Analytical, Environmental and Forensic Sciences King's College London London UK

3. Swansea University Medical School, The Grove Swansea University Swansea UK

4. Department of Psychology Guglielmo Marconi University Rome Italy

Publisher

Wiley

Subject

Molecular Medicine,Biochemistry,Drug Discovery,Pharmacology,Organic Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cbdd.14119

Reference58 articles.

1. ACMD. (2020a).Addendum to ACMD's report on novel benzodiazepines. Retrieved January 31 2022 fromhttps://www.gov.uk/government/publications/novel‐benzodiazepines‐prevalence‐and‐harms‐in‐the‐uk/addendum‐to‐acmds‐report‐on‐novel‐benzodiazepines

2. ACMD. (2020b).Novel benzodiazepines a review of the evidence of use and harms of novel benzodiazepines. Retrieved fromhttps://www.gov.uk

3. How does α1Histidine102 affect the binding of modulators to α1β2γ2 GABAA receptors? molecular insights from in silico experiments

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Applications and Potential of In Silico Approaches for Psychedelic Chemistry;Molecules;2023-08-09

2. Designer Benzodiazepines: Effects, Toxicity, and Interactions;Therapeutic Drug Monitoring;2023-01-27